---
title: 'A ten-year comparison of treatment and outcomes of cancer-associated thrombosis
  to non-cancer venous thromboembolism: from traditional anticoagulants to direct
  oral anticoagulants'
date: '2024-02-23'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38393675/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240223170739&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: DOACs have emerged as first-line treatment in most cancer-associated
  thrombosis (CAT), representing a paradigm shift in its management. However, CAT
  management remains challenging and requires careful risk-benefit considerations.
  A retrospective analysis of CAT presentations to a tertiary referral centre from
  January 2011 to December 2020. Outcomes in CAT patients were compared to VTE patients
  without malignancy. Subgroup analysis was also conducted for CAT according to anticoagulation
  type. ...
disable_comments: true
---
DOACs have emerged as first-line treatment in most cancer-associated thrombosis (CAT), representing a paradigm shift in its management. However, CAT management remains challenging and requires careful risk-benefit considerations. A retrospective analysis of CAT presentations to a tertiary referral centre from January 2011 to December 2020. Outcomes in CAT patients were compared to VTE patients without malignancy. Subgroup analysis was also conducted for CAT according to anticoagulation type. ...